FNY Investment Advisers’s RxSight RXST Stock Holding History

FNY Investment Advisers’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,400	Closed	-$126K	–	740
2023 Q2	$126K	Buy	+4,400	New	+$97.9K	0.16%	91

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

FNY Investment Advisers's RXST Position: Q3 2023 in Review

FNY Investment Advisers sold out of RxSight (RXST) in Q3 2023, closing a stake of 4,400 shares — an estimated $126K sold.

FNY Investment Advisers first reported a position in RXST in Q2 2023 and held it in 1 quarter. The position peaked at $126K in Q2 2023. 128 funds tracked by Wall St. Rank hold RXST as of Q3 2023.

FNY Investment Advisers reported no remaining RxSight position as of Q3 2023 after selling out during the quarter.
FNY Investment Advisers sold 4,400 RxSight shares in Q3 2023, an estimated $126K.
FNY Investment Advisers first reported a position in RxSight in Q2 2023 and held it in 1 quarter.
FNY Investment Advisers's RxSight position peaked at $126K in Q2 2023.
128 funds tracked by Wall St. Rank held RxSight as of Q3 2023.

Based on FNY Investment Advisers's 13F filing for Q3 2023, filed 10 Oct 2023.